What is the Center for Personalized Diagnostics (CPD)?
The CPD aims to uncover genetic mutations within a patient's own cancer that can allow for a more targeted and personalized "precision" treatment strategy. The CPD is a joint program and collaboration between Penn’s Department of Pathology and Laboratory Medicine and the Abramson Cancer Center. That means our pathologists work hand-in-hand with your oncologist to determine the best course of action for your cancer treatment, based on the genomic test results and your specific needs.
Learn more about our initiative and services on our website.
What is personalized or precision medicine?
Personalized medicine aims to individualize treatments to match each patient with the therapy they are most likely to respond to by assessing the patients’ unique genomic alterations or background. This allows your medical team to more precisely deliver the right treatment, to the right person, at the right time.
What does cancer have to do with genomic alterations?
Cancer is just normal cells that have acquired genetic mutations that make those cells become “cancer” cells.